$INVA

$20.96 -$0.10 (0.45%) Live

$INVA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 72.2M shares outstanding

Who owns INVA?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 55.7%

BlackRock, Inc. 16.0% · Dimensional Fund Advisors LP 6.2%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

305

+20 vs last qtr

Net shares bought

−1.1M

by institutions in Q2 2026

New / sold out

46 / 26

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Bridgeway Capital Management, LLC +326.1K
Baird Financial Group, Inc. NEW +274.4K

Biggest sellers in Q2 2026

Arrowstreet Capital, Limited Partnership −1.5M
Man Group plc SOLD OUT −744.8K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Innoviva, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025

−31.2%

−4.07% a year

Each share's claim on the business

+45.4%

grew without buying or selling a share

Spent on buybacks vs paid in stock

$673M vs $56.1M

over 10 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years76% 3–5 years7% 1–3 years12% Under 1 year6%

Quarterly turnover

7.4%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting INVA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	11.6M	15.99%	+247.4K (+2.2%)	≤2021	0.0%
Shares held by quarter Peak holding11.6M (Q2'26) Change over 8 quarters+2.1M Share of the company15.990% BlackRock, Inc.'s full portfolio →
DF Dimensional Fund Advisors LP	4.5M	6.22%	+57.6K (+1.3%)	≤2021	0.0%
Shares held by quarter Peak holding4.9M (Q4'24) Change over 8 quarters−198.9K Share of the company6.220% Dimensional Fund Advisors LP's full portfolio →

BlackRock, Inc.

11.6M

% of company

15.99%

Change vs last qtr

+247.4K (+2.2%)

Held since

≤2021

Dimensional Fund Advisors LP

4.5M

% of company

6.22%

Change vs last qtr

+57.6K (+1.3%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Innoviva, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting INVA on Form N-PORT; together they hold 48.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IC iShares Core S&P Small-Cap ETF iShares Trust	$96M	4.2M	5.85%	0.09%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$50.7M	2.2M	3.09%	0.00%	June 30, 2026

iShares Core S&P Small-Cap ETF

iShares Trust

Position value

$96M

% of company

5.85%

% of the fund

0.09%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$50.7M

% of company

3.09%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Innoviva, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
DA Denner Alexander J 5%+ holder 13D · 4.7%	3.0M	4.11%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company4.110% Disclosed stake13D · 4.7% View the 13D/G filing →
RP Raifeld Pavel Insider	284.8K	0.39%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.390% Raifeld Pavel's insider activity →

Denner Alexander J

5%+ holder13D · 4.7%

3.0M

% of company

4.11%

Change vs last qtr

—

Held since

—

Raifeld Pavel

Insider

284.8K

% of company

0.39%

Change vs last qtr

—

Held since

—

7 more holders behind a free account

See every insider and 5%+ holder of Innoviva, Inc..

Comments